Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Res Adolesc ; 28(2): 284-293, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29570899

RESUMEN

Although adolescents experience an array of out-of-school time (OST) settings, research has primarily focused on these settings in isolation. This study examined time in four OST settings (unsupervised time with peers, paid employment, sports, and nonsports organized activities) in relation to adolescent functioning at age 15 and the end of high school. Individual fixed effects analyses provided a more rigorous control of selection into OST activities by controlling for time-invariant observable and unobservable characteristics. More unsupervised time with peers predicted increases in risky and externalizing behaviors, whereas increases in paid employment predicted gains in work orientation and self-identity. Time in organized sports was associated with increased positive self-identity, highlighting the value of expanding consideration of multiple OST contexts and selection effects.


Asunto(s)
Conducta del Adolescente/psicología , Empleo/estadística & datos numéricos , Aislamiento Social/psicología , Deportes/estadística & datos numéricos , Adolescente , Empleo/psicología , Femenino , Humanos , Actividades Recreativas/psicología , Estudios Longitudinales , Masculino , Grupo Paritario , Asunción de Riesgos , Autoimagen , Medio Social , Deportes/psicología
2.
Cold Spring Harb Protoc ; 2014(10): pdb.prot084160, 2014 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-25275111

RESUMEN

Various devices have been used to flow neurotransmitter solutions over cells containing receptors (e.g., ligand-gated ion channels) for whole-cell current recordings. With many of the devices, the orientation between the porthole of the flow device and the cell is not maintained absolutely constant. Orientation is critical for reproducibility in kinetic experiments. To be able to change the composition of the flowing solution during an experiment and still maintain a constant orientation, we use the cell-flow device described here. A peristaltic pump, a stainless steel U-tube, two different sizes of peristaltic tubing, and a solenoid valve are required to create a simple solution exchange system that can rapidly apply and remove solutions over the surface of a cell in tens of milliseconds. This system allows one to test multiple conditions on a cell containing the receptor of interest while constantly "washing" the cell with extracellular buffer solution between experimental applications. The use of the solenoid valve allows for the application of solutions to be precisely timed and controlled by a computer during electrophysiological current recording.


Asunto(s)
Potenciales de Acción/efectos de los fármacos , Electrofisiología/métodos , Flujo Pulsátil , Soluciones/administración & dosificación , Potenciales de Acción/fisiología , Animales , Células Cultivadas , Electrofisiología/instrumentación , Humanos , Bombas de Infusión Implantables , Cinética , Neurotransmisores/administración & dosificación , Técnicas de Placa-Clamp , Ratas
3.
Cold Spring Harb Protoc ; 2014(10): pdb.top084152, 2014 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-25275116

RESUMEN

The approaches using caged neurotransmitters described here enable transient kinetic investigations to be made with membrane-bound proteins (receptors) on a cell surface with the same time resolution as was previously possible only with proteins in solution.


Asunto(s)
Neuronas/fisiología , Neurotransmisores/metabolismo , Fotoquímica/métodos , Fotólisis , Animales , Células Cultivadas , Humanos , Neuronas/efectos de los fármacos , Neurotransmisores/química , Receptores de Neurotransmisores/metabolismo
4.
Proc Natl Acad Sci U S A ; 108(44): 18132-7, 2011 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-22006306

RESUMEN

Firing of action potentials in excitable cells accelerates ATP turnover. The voltage-gated potassium channel Kv2.1 regulates action potential frequency in central neurons, whereas the ubiquitous cellular energy sensor AMP-activated protein kinase (AMPK) is activated by ATP depletion and protects cells by switching off energy-consuming processes. We show that treatment of HEK293 cells expressing Kv2.1 with the AMPK activator A-769662 caused hyperpolarizing shifts in the current-voltage relationship for channel activation and inactivation. We identified two sites (S440 and S537) directly phosphorylated on Kv2.1 by AMPK and, using phosphospecific antibodies and quantitative mass spectrometry, show that phosphorylation of both sites increased in A-769662-treated cells. Effects of A-769662 were abolished in cells expressing Kv2.1 with S440A but not with S537A substitutions, suggesting that phosphorylation of S440 was responsible for these effects. Identical shifts in voltage gating were observed after introducing into cells, via the patch pipette, recombinant AMPK rendered active but phosphatase-resistant by thiophosphorylation. Ionomycin caused changes in Kv2.1 gating very similar to those caused by A-769662 but acted via a different mechanism involving Kv2.1 dephosphorylation. In cultured rat hippocampal neurons, A-769662 caused hyperpolarizing shifts in voltage gating similar to those in HEK293 cells, effects that were abolished by intracellular dialysis with Kv2.1 antibodies. When active thiophosphorylated AMPK was introduced into cultured neurons via the patch pipette, a progressive, time-dependent decrease in the frequency of evoked action potentials was observed. Our results suggest that activation of AMPK in neurons during conditions of metabolic stress exerts a protective role by reducing neuronal excitability and thus conserving energy.


Asunto(s)
Proteínas Quinasas Activadas por AMP/metabolismo , Canales de Potasio Shab/metabolismo , Potenciales de Acción , Animales , Línea Celular , Membrana Celular/efectos de los fármacos , Membrana Celular/metabolismo , Activación Enzimática , Humanos , Ionomicina/farmacología , Fosforilación , Ratas
5.
Future Med Chem ; 3(2): 243-50, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21428818

RESUMEN

We discuss the potential use of multicomponent reactions in developing small-molecule probes of GABA(A) receptor function. Two examples that illustrate this approach are presented: the synthesis of a class of compounds that specifically modulate the function of GABA(A) receptors containing the δ-subunit, and also 'caged' GABA derivatives. A caged GABA is a photolabile precursor of GABA that releases GABA upon photolysis.


Asunto(s)
Receptores de GABA-A/metabolismo , Ácido gamma-Aminobutírico/química , Ácido gamma-Aminobutírico/metabolismo , Células HEK293 , Humanos , Estructura Molecular , Fotoquímica/métodos , Fotólisis , Pirimidinonas/síntesis química , Pirimidinonas/química , Receptores de GABA-A/química
6.
Biochemistry ; 49(23): 4841-51, 2010 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-20450160

RESUMEN

Gamma-aminobutyric acid type A receptors (GABA(A) receptors) are ligand-gated chloride channels that play a central role in signal transmission within the mammalian central nervous system. Compounds that modulate specific GABA(A) receptor subtypes containing the delta-subunit are scarce but would be valuable research tools and starting points for potential therapeutic agents. Here we report a class of dihydropyrimidinone (DHPM) heterocycles that preferentially potentiate peak currents of recombinant GABA(A) receptor subtypes containing the delta-subunit expressed in HEK293T cells. Using the three-component Biginelli reaction, 13 DHPMs with structural features similar to those of the barbiturate phenobarbital were synthesized; one DHPM used (monastrol) is commercially available. An up to approximately 3-fold increase in the current from recombinant alpha1beta2delta receptors was observed with the DHPM compound JM-II-43A or monastrol when co-applied with saturating GABA concentrations, similar to the current potentiation observed with the nonselective potentiating compounds phenobarbital and tracazolate. No agonist activity was observed for the DHPMs at the concentrations tested. A kinetic model was used in conjunction with dose-dependent measurements to calculate apparent dissociation constant values for JM-II-43A (400 muM) and monastrol (200 microM) at saturating GABA concentrations. We examined recombinant receptors composed of combinations of subunits alpha1, alpha4, alpha5, alpha6, beta2, beta3, gamma2L, and delta with JM-II-43A to demonstrate the preference for potentiation of delta-subunit-containing receptors. Lastly, reduced currents from receptors containing the mutated delta(E177A) subunit, described by Dibbens et al. [(2004) Hum. Mol. Genet. 13, 1315-1319] as a heritable susceptibility allele for generalized epilepsy with febrile seizures plus, are also potentiated by these DHPMs.


Asunto(s)
Epilepsia/genética , Epilepsia/metabolismo , Variación Genética , Subunidades de Proteína/metabolismo , Pirimidinonas/farmacología , Receptores de GABA-A/genética , Receptores de GABA-A/metabolismo , Alanina/genética , Regulación Alostérica/genética , Línea Celular , Sinergismo Farmacológico , Ácido Glutámico/genética , Humanos , Mutagénesis Sitio-Dirigida , Unión Proteica/efectos de los fármacos , Isoformas de Proteínas/genética , Isoformas de Proteínas/metabolismo , Pirimidinas/farmacología , Tionas/farmacología
7.
Bioorg Med Chem Lett ; 19(14): 3932-3, 2009 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-19364648

RESUMEN

A short and convergent synthetic approach to new photoactivatable precursors of gamma-aminobutyric acid (GABA) is described. When photolyzed, the 'caged' GABA precursor efficiently releases GABA, as judged by depolarization measurements on the mammalian GABA(A) receptor.


Asunto(s)
Neurotransmisores/síntesis química , Receptores de GABA-A/metabolismo , Ácido gamma-Aminobutírico/química , Línea Celular , Electrodos , Electrofisiología , Antagonistas de Receptores de GABA-A , Humanos , Neurotransmisores/química , Neurotransmisores/farmacología , Ácido gamma-Aminobutírico/síntesis química , Ácido gamma-Aminobutírico/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA